Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Blank

Showing results (101-110 of 317) with videos related to

Pageof 32
Sort By:
Oncoimmunology|February 5, 2019
Batf3<sup>+</sup> DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapyJing Liu, Elisa A Rozeman, Jake S O'Donnell, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2016
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanomaPaula Kroon, Jules Gadiot, Marlies Peeters, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2016
[No hair loss, but colitis or pneumonitis: unique side effects of immune checkpoint inhibitors for cancer]T G Steenbruggen, M M van den Heuvel, C U Blank, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2025
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma - A Swedish retrospective real-world study (NEO-MEL)Axel Nelson, Ellen Krabbe, Karl Björkström, et al.
Immunity|January 1, 2026
Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicityMinke W Lucas, Elizabeth M Burton, Petros Dimitriadis, et al.
Urology|August 7, 2017
Observation After Cytoreductive Nephrectomy in Patients With Synchronous Not Completely Resected Metastases of Renal Cell CarcinomaRoderick E de Bruijn, Teele Kuusk, Allard P Noe, et al.
Journal of Cardiac Failure|April 4, 2000
Chronic endothelin blockade in dogs with pacing-induced heart failure: possible modulation of sympathoexcitationP I McConnell, C E Olson, K P Patel, et al.
FEBS Letters|February 3, 1999
Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated plateletsM Laffargue, J M Ragab-Thomas, A Ragab, et al.
Journal of Analytical Toxicology|October 19, 2011
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patientNienke A G Lankheet, Christian U Blank, Henk Mallo, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2025
Dissecting response to neoadjuvant immunotherapy-treated melanoma using cancer-immunity cycle-associated signaturesS C M A Wijnen, P Dimitriadis, I L M Reijers, et al.
Pageof 32

Showing results (101-110 of 317) with videos related to

Sort By:
Pageof 32
Oncoimmunology|February 5, 2019
Batf3<sup>+</sup> DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapyJing Liu, Elisa A Rozeman, Jake S O'Donnell, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2016
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanomaPaula Kroon, Jules Gadiot, Marlies Peeters, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2016
[No hair loss, but colitis or pneumonitis: unique side effects of immune checkpoint inhibitors for cancer]T G Steenbruggen, M M van den Heuvel, C U Blank, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2025
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma - A Swedish retrospective real-world study (NEO-MEL)Axel Nelson, Ellen Krabbe, Karl Björkström, et al.
Immunity|January 1, 2026
Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicityMinke W Lucas, Elizabeth M Burton, Petros Dimitriadis, et al.
Urology|August 7, 2017
Observation After Cytoreductive Nephrectomy in Patients With Synchronous Not Completely Resected Metastases of Renal Cell CarcinomaRoderick E de Bruijn, Teele Kuusk, Allard P Noe, et al.
Journal of Cardiac Failure|April 4, 2000
Chronic endothelin blockade in dogs with pacing-induced heart failure: possible modulation of sympathoexcitationP I McConnell, C E Olson, K P Patel, et al.
FEBS Letters|February 3, 1999
Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated plateletsM Laffargue, J M Ragab-Thomas, A Ragab, et al.
Journal of Analytical Toxicology|October 19, 2011
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patientNienke A G Lankheet, Christian U Blank, Henk Mallo, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2025
Dissecting response to neoadjuvant immunotherapy-treated melanoma using cancer-immunity cycle-associated signaturesS C M A Wijnen, P Dimitriadis, I L M Reijers, et al.
Pageof 32